Contineum Therapeutics (CTNM) Earnings Date, Estimates & Call Transcripts

→ Nvidia is now part of $3 Trillion Market Cap Club (From Weiss Ratings) (Ad)

Free CTNM Stock Alerts

$16.66

+0.71 (+4.45%)

(As of 06/12/2024 ET)

Compare

Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials SEC Filings Trends

Upcoming Earnings Date: Aug. 15Estimated
Actual EPS (May. 16): -$3.55 Missed By -$3.02
Consensus EPS (May. 16): -$0.53

Earnings Per Share Revenue

CTNM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CTNM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Stansberry Research

Wall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"

Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.

Learn more here.

Contineum Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.95) EPS
Next Year EPS Consensus Estimate: ($1.83) EPS

CTNM Earnings Date and Information

Contineum Therapeutics last posted its quarterly earnings results on May 16th, 2024. The reported ($3.55) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $3.02. Contineum Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Contineum Therapeutics are expected to grow in the coming year, from ($1.95) to ($1.83) per share. Contineum Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 15th, 2024 based off prior year's report dates.

Contineum Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue	Call Transcript
8/15/2024 (Estimated)	-	-	-	-	-	-	-
5/16/2024	Q1 2024	($0.53)	($3.55)	($3.02)	($3.55)	-	-

Contineum Therapeutics Earnings - Frequently Asked Questions

When is Contineum Therapeutics's earnings date?: Contineum Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 15th, 2024 based off last year's report dates. Learn more on CTNM's earnings history.
Did Contineum Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Contineum Therapeutics (NASDAQ:CTNM) missed the analysts' consensus estimate of ($0.53) by $3.02 with a reported earnings per share (EPS) of ($3.55). Learn more on analysts' earnings estimate vs. CTNM's actual earnings.
What is Contineum Therapeutics's EPS forecast for next year?: Contineum Therapeutics's earnings are expected to grow from ($1.95) per share to ($1.83) per share in the next year.